BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Precious Metal Recovery Specialist, PhosphonicS, Appoints Linda Bell as CEO


5/22/2013 9:22:35 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

(Oxford, UK, 20 May 2013) PhosphonicS Ltd, a leading precious metal recovery specialist, today announced the appointment of Dr Linda Bell as chief executive officer with immediate effect.

PhosphonicS uses proprietary chemistry to create ‘scavenger’ products based on functionalised silicas that enable the recovery of precious metals from industrial production processes and waste streams on a cost-effective basis. Clients include major mining companies, petroleum refineries, electronics companies and pharmaceutical and chemical firms worldwide.

The new CEO appointment will support the next stage in development of the company’s services and expansion of its operations.

Dr Bell has extensive experience of leading and growing science based international businesses in a range of industrial and process industries. She has also held senior management roles with plastics and speciality chemicals businesses including ICI.

Dr Bell joins from FTSE 250 global packaging group, DS Smith plc, where she was managing director of the liquid packaging and dispensing division with responsibility for six European sites. Prior to DS Smith she held a position as chief executive officer with Inca Digital Printers Ltd, an innovative large format digital inkjet technology company and subsidiary of Nikkei listed Dainippon Screen.

Dr Bell has also served as managing director of Servomex Group Ltd, part of Spectris plc. Servomex markets gas analysis instrumentation to blue chip companies in the petrochemical and chemical, metals and minerals, marine, laboratory and healthcare fields. Prior to Servomex, she held director and commercial management positions with ICI plc. Dr Bell holds a D.Phil in organometallic chemistry from the University of Oxford.

Dr Bell said: “PhosphonicS has a very exciting range of product application opportunities and is at the forefront of the development of advanced functionalised materials used to recover precious metals from a wide range of processes. I am delighted to be working with such a talented team to take the company to the next stage of its development.”

Commenting on the appointment, PhosphonicS chairman Nick Cross said: “It is a great pleasure to welcome Linda to PhosphonicS. She brings considerable strategic, operational and commercial expertise to the company and will be instrumental in growing the business.”

Dr David Astles, who led the early development of the company and managed its transition from laboratory technology to commercialisation, has stepped down as CEO to pursue other opportunities. He will remain available to PhosphonicS as a consultant for up to twelve months.

Contact

Margaret Henry

PR Consultant

PhosphonicS

T: + 44 (0) 1865 261491

M: + 44 (0) 7771 377363

E: m.henry@oxin.co.uk

About PhosphonicS

PhosphonicS is a world leading developer of precious metal recovery processes in the Cleantech sector.

The company’s precious metal scavenger products enable the recovery and recycling of precious metals from refinery and mining processes and waste streams. Its small molecule purification process offers by-product and impurity removal from product streams, covering pharmaceutical, fine and speciality chemicals.

Precious metal catalysts are used in hydroformylation and hydrogenation reactions, in silane production, and in a range of chemicals processing. These catalysts rely on expensive platinum group metals: platinum, palladium rhodium, iridium gold and ruthenium. During processing and production some of these metals are recovered but significant amounts are lost, particularly in low concentration streams. Traditional incineration or extraction technologies cannot economically process streams below 10 parts per million.

PhosphonicS has estimated that $1.5bn of recoverable metal is being lost in low concentration streams across the chemical, petroleum and other industries.

The company’s materials allow the economic recovery of platinum group metals from low concentration industrial streams. Clients include a rapidly growing base of major mining companies, petroleum refineries, electronics manufacturers and pharmaceutical and chemical firms worldwide.

PhosphonicS is backed by a combination of private investors and venture capital funds. Its facility at Milton Park, Oxfordshire, UK, incorporates R&D, application development and customer support activities.

For more information: www.phosphonics.com



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES